Related Experiment Videos
[Unfolding chaperone as a prion protein relating molecule]
Rinsho Shinkeigaku = Clinical Neurology
|May 22, 2004
Summary
Researchers identified a novel molecular chaperone from S. cerevisiae with ATP-dependent protein unfolding activity. This chaperone can unfold misfolded prion protein (PrP) and other disease-associated proteins, offering potential therapeutic insights for prion diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Prion diseases like mad cow disease are caused by misfolded prion protein (PrPSc) isoforms.
- Cellular prion protein (PrPc) and PrPSc share identical amino acid sequences but differ in conformation.
- A host factor, potentially a molecular chaperone, may facilitate the conformational change from PrPc to PrPSc.
Purpose of the Study:
- To investigate the existence and function of a molecular chaperone capable of unfolding misfolded protein structures.
- To identify and characterize a novel chaperone with potential activity against prion protein.
Main Methods:
- Construction of an assay system to detect protein unfolding activity.
- Purification of a novel molecular chaperone from S. cerevisiae.
- Testing the chaperone's activity against various misfolded proteins, including beta-sheet rich PrP, alpha-synuclein, and A beta.
- Assessing the role of ATP and identifying the chaperone's oligomeric structure.
Main Results:
- A novel molecular chaperone with broad-spectrum protein unfolding activity was purified from S. cerevisiae.
- The chaperone demonstrated ATP-dependent activity against beta-sheet rich PrP, alpha-synuclein, and A beta.
- The chaperone possesses an oligomeric ring-like structure with a central cavity.
- Activity was reduced by ATP hydrolysis, confirming its ATP-dependent nature and oligomeric assembly (4-5 subunits).
Conclusions:
- A novel ATP-dependent molecular chaperone with protein unfolding capabilities has been identified.
- This chaperone effectively targets misfolded prion protein and other aggregation-prone proteins.
- The findings suggest a potential therapeutic target for prion and other neurodegenerative diseases.